[
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-1",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#definitiongeneral475391",
    "clean_content": "Definition / general\n\n* First described by Chan et al. in 1992 ([Am J Surg Pathol 1992;16:335](1373579))* Rare and benign vascular disorder due to proliferation of blood vessels and smooth muscle in mostly the hilar region of lymph nodes, often of long duration"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-2",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#essentialfeatures475392",
    "clean_content": "Essential features\n\n* Variably sized, thick walled blood vessels and haphazardly arranged smooth muscles in sclerotic nodal parenchyma* Benign lesion with no atypia* Uncommon process, usually asymptomatic and often solitary* Prominent smooth muscle infiltrate (SMA) with low proliferative fraction* HMB45 negative (to distinguish from angiomyolipoma)"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-3",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#icdcoding475394",
    "clean_content": "ICD coding\n\n* ICD-11\n  + [BD9Y](https://icd.who.int/browse/2024-01/mms/en#1025888387%2Fother) - other specified disorders of lymphatic vessels or lymph nodes+ [MA01.0](https://icd.who.int/browse/2024-01/mms/en#667642868) - localized lymph node enlargement"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-4",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#epidemiology475395",
    "clean_content": "Epidemiology\n\n* M > F ([Blood 2020;136:1794](33031529))* All ages, peaking at sixth decade ([Hum Pathol 2017;68:175](28899738))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-5",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#sites475396",
    "clean_content": "Sites\n\n* Mostly involves inguinal or femoral lymph nodes, usually solitary* May have associated limb edema; rare case report with a soft tissue mass ([JAAD Case Rep 2022;27:117](36042974))* Rare reports of cervical lymph node and popliteal lymph node involvement ([Histopathology 1996;29:80](8818701), [Ann Diagn Pathol 2008;12:372](18774503))* Rarely presents as extensive lymphadenopathy ([Blood 2020;136:1794](33031529))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-6",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#etiology475398",
    "clean_content": "Etiology\n\n* Unknown etiology; may represent reparative reaction to previous nodal inflammation or chronic blockage of nodal lymphatic flow ([BMC Pediatr 2012;12:172](23130960))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-7",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#clinicalfeatures475400",
    "clean_content": "Clinical features\n\n* Presents incidentally or as palpable nodule; rare report of lymphadenomegaly in different regions ([Blood 2020;136:1794](33031529))* Typically asymptomatic; rarely lymphedema of ipsilateral limb ([Fed Pract 2016;33:38](30930616))* Benign clinical course* No known recurrence or metastasis"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-8",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#diagnosis475401",
    "clean_content": "Diagnosis\n\n* Excisional biopsy of lymph node usually diagnostic"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-9",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#radiologydescription475403",
    "clean_content": "Radiology description\n\n* Magnetic resonance imaging (MRI): well circumscribed solitary nodule with heterogeneous signal intensity ([JAAD Case Rep 2022;27:117](36042974))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-10",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#casereports475406",
    "clean_content": "Case reports\n\n* 33 year old man with postauricular lymph node, clinically masquerading as epidermal inclusion cyst ([JAAD Case Rep 2020;7:131](33426252))* 37 year old woman with weight loss and para-aortic lymph node ([Prz Menopauzalny 2023;22:111](37674923))* 53 year old woman with multiple neck lymph nodes showing angiomyomatous hamartoma ([Int J Surg Pathol 2023 Nov 20 [Epub ahead of print]](38124308))* 60 year old man with several year history of lower leg edema ([Case #118](https://www.pathologyoutlines.com/caseofweek/case2008118.htm))* 63 year old woman with right femoral subcutaneous mass and localized lymphedema ([JAAD Case Rep 2022;27:117](36042974))* 75 year old man with incidental extensive lymphadenopathy involving mediastinal, retroperitoneal, pelvic, inguinal and para-aortal lymph nodes ([Blood 2020;136:1794](33031529))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-11",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#treatment475407",
    "clean_content": "Treatment\n\n* Surgical excision is curative"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-12",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#grossdescription475409",
    "clean_content": "Gross description\n\n* Enlarged lymph node replaced by firm, white tissue"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-13",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#grossimages475410",
    "clean_content": "Gross images\n\nAFIP images  \n\n[![](https://www.pathologyoutlines.com/imgau/afip21_007.jpg)](https://www.pathologyoutlines.com/imgau/afip21_007.jpg)\n\nReplacement by tan, firm tissue"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-14",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#microscopichistologicdescription475413",
    "clean_content": "Microscopic (histologic) description\n\n* Extensive and multifocal nodal involvement by thick walled hilar blood vessels, often with increased fibrous tissue* Nodal parenchyma has haphazard smooth muscle fibers in sclerotic stroma* Starts in nodal hilum and extends toward cortex* May have admixed adipose tissue* No cellular atypia, pleomorphism or necrosis; low mitotic rate ([Hum Pathol 2017;68:175](28899738))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-15",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#microscopichistologicimages475414",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Patricia Tsang, M.D., M.B.A., Vincent A. Graffeo, M.D. and AFIP  \n\n[![Disarrayed vascular proliferation](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang1.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang1.jpg)\n\nDisarrayed vascular proliferation\n\n[![Angiomyomatous proliferation](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang2.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang2.jpg)\n\nAngiomyomatous proliferation\n\n[![Smooth muscle proliferation](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang3.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang3.jpg)\n\nSmooth muscle proliferation\n\n[![Thick walled vasculature](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang4.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang4.jpg)\n\nThick walled vasculature\n\n[![Abnormal blood vessels](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang5.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang5.jpg)\n\nAbnormal blood vessels\n\n  \n\n[![](https://www.pathologyoutlines.com/caseofweek/case118image1.jpg)](https://www.pathologyoutlines.com/caseofweek/case118image1.jpg)\n \n[![Angiomyomatous proliferation](https://www.pathologyoutlines.com/caseofweek/case118image4.jpg)](https://www.pathologyoutlines.com/caseofweek/case118image4.jpg)\n\nAngiomyomatous proliferation\n\n[![Thick walled vessels](https://www.pathologyoutlines.com/caseofweek/case118image2.jpg)](https://www.pathologyoutlines.com/caseofweek/case118image2.jpg)\n\nThick walled vessels\n\n[![Disarrayed smooth muscles](https://www.pathologyoutlines.com/caseofweek/case118image3.jpg)](https://www.pathologyoutlines.com/caseofweek/case118image3.jpg)\n\nDisarrayed smooth muscles\n\n  \n\n[![](https://www.pathologyoutlines.com/imgau/afip21_008.jpg)](https://www.pathologyoutlines.com/imgau/afip21_008.jpg)\n \n[![](https://www.pathologyoutlines.com/imgau/afip21_009.jpg)](https://www.pathologyoutlines.com/imgau/afip21_009.jpg)\n \n[![](https://www.pathologyoutlines.com/imgau/afip21_010.jpg)](https://www.pathologyoutlines.com/imgau/afip21_010.jpg)\n\nAngiomyomatous hamartoma of lymph node\n\n[![Smooth muscle actin](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang6.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang6.jpg)\n\nSmooth muscle actin\n\n[![CD31](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang7.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesangiomyomatoushamartomaMicroTsang7.jpg)\n\nCD31"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-16",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#positivestains475420",
    "clean_content": "Positive stains\n\n* [Smooth muscle actin](https://www.pathologyoutlines.com/topic/stainsalphasmoothmuscleactin.html), [caldesmon](https://www.pathologyoutlines.com/topic/stainscaldesmon.html) and [desmin](https://www.pathologyoutlines.com/topic/stainsdesmin.html) stain smooth muscle fibers* [CD31](https://www.pathologyoutlines.com/topic/cdmarkerscd31.html) and [CD34](https://www.pathologyoutlines.com/topic/cdmarkerscd34.html) highlight endothelial cells ([Int J Surg Pathol 2023 Nov 20 [Epub ahead of print]](38124308))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-17",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#negativestains475421",
    "clean_content": "Negative stains\n\n* [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html) and [cathepsin K](https://www.pathologyoutlines.com/topic/stainscathepsink.html), in contrast to angiomyolipoma and lymphangioleiomyomatosis* [Ki67](https://www.pathologyoutlines.com/topic/stainski67.html) is mostly negative (low proliferation) ([Int J Surg Pathol 2023 Nov 20 [Epub ahead of print]](38124308))"
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-18",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#samplepathologyreport475429",
    "clean_content": "Sample pathology report\n\n* Inguinal lymph node, excision:\n  + Angiomyomatous hamartoma of lymph node (see comment)+ Comment: The nodal architecture is disrupted by a haphazard proliferation of thick walled vasculature and smooth muscle bundles. Occasional adipocytes are admixed. No cytologic atypia or mitoses are seen. Residual lymphoid tissue with reactive lymphoid follicles is present in the cortex. Immunohistochemistry shows CD31 and SMA highlighting the endothelial cells and smooth muscles, respectively. HMB45 is negative."
  },
  {
    "id": "angiomyomatous-hamartoma_46445_1750165656.txt-19",
    "source_document": "angiomyomatous-hamartoma_46445_1750165656.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesangiomyomatoushamartoma.html#differentialdiagnosis475430",
    "clean_content": "Differential diagnosis\n\n* [Angiolipomatous hamartoma](https://www.pathologyoutlines.com/topic/lymphnodesangiolipomatoushyperplasia.html):\n  + Various nodal sites, including cervical, mediastinal and retroperitoneal lymph nodes+ Miscellaneous extranodal sites may be involved+ Associated with [Castleman disease](https://www.pathologyoutlines.com/topic/lymphnodescastleman.html)* [Angiomyolipoma](https://www.pathologyoutlines.com/topic/lymphnodesangiomyolipoma.html):\n    + [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html)++ Typically involves retroperitoneal nodes+ Associated with [renal angiomyolipoma](https://www.pathologyoutlines.com/topic/kidneytumorangiomyolipoma.html)* [Lymphangiomatosis](https://www.pathologyoutlines.com/topic/lymphnodeslymphangioma.html) ([Lymphat Res Biol 2011;9:191](22196284)):\n      + Commonly in children and young adults, may be congenital+ Frequently involves lung with pleural effusion and other thoracic locations; also in bone, spleen and liver; primary nodal is rare+ Smooth muscle fascicles around anastomosing dilated vascular spaces lined by flat endothelial cells* [Lymphangioleiomyomatosis](https://www.pathologyoutlines.com/topic/lymphnodeslymphangiomyomatosis.html):\n        + Female predominance+ Lungs and occasionally retroperitoneal lymph nodes+ [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html)+ and [cathepsin K](https://www.pathologyoutlines.com/topic/stainscathepsink.html)++ Thin walled lymphatic channels and spindle cells in a fascicular pattern* [Vascular transformation of lymph node sinuses](https://www.pathologyoutlines.com/topic/lymphnodesvasculartransformationofsinuses.html) ([Am J Surg Pathol 1991;15:732](2069211)):\n          + Small capillary vascular channels replacing nodal subcapsular sinuses+ Reactive process often accompanied by fibrosis; no cytologic atypia+ Involves single or multiple lymph nodes in a diffuse or segmental fashion"
  }
]